Thursday, September 21, 2017 3:10:20 PM
NEW YORK, GLOBE NEWSWIRE) -- PHI Group, Inc., (www.phiglobal.com) (PHIL), a company focused on mergers and acquisitions and investments in natural resources, energy, agriculture, healthcare and special situations, announced today that it has formed PHIVITAE Corp., a Wyoming corporation, to serve as a holding subsidiary of the Company for pharmaceutical and healthcare-related business and signed a Letter of Intent (“LOI”) to acquire 80% of a 20-year old profitable European company that is engaged in pharmaceutical and medical device distribution.
According to the LOI, the Company will enter into a definitive purchase and sale agreement with the European target and will make cash payments for the purchase price, which will be finalized after completion of ongoing due diligence.
The Company intends to use the European target as a platform to distribute prized organic medicines developed by Tho Xuan Duong JSC, a company recognized by Guinness World Records with nearly four centuries of history in Vietnamese traditional medicine and herbs (www.thoxuanduong.com). It will also distribute FDA-cleared innovative medical devices using Low Level Laser Light Therapy technologies developed by American Laser Healthcare Corp, a Delaware corporation (Youtube: Mac Beam Inc), and other selective pharmaceutical products to the European markets.
The Company will announce further details after the signing of the definitive purchase and sale agreement and plans to close this transaction in six to eight weeks.
Henry Fahman, CEO of PHI Group, said, “We are very excited to acquire a majority interest in this European target which can serve as a platform to provide a variety of prized pharmaceutical products and medical devices to European countries and other geographical areas. The conclusion of this transaction will allow us to immediately consolidate its revenues and profits, which will potentially help our top and bottom lines as well as enhance our valuation in the market.”
Recent PHIL News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 03/11/2024 10:05:47 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 12:34:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/26/2023 03:00:09 PM
- US Airforce Contract Awarded to Epazz, Inc. (OTC Pink: EPAZ) • InvestorsHub NewsWire • 12/14/2023 11:48:21 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/13/2023 08:40:50 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:15:52 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/13/2023 09:33:15 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:10:38 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:30:15 PM
- Airbus, PHI Group Sign Deal for 28 Helicopters • Dow Jones News • 09/12/2023 01:58:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/03/2023 12:00:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/29/2023 03:30:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/28/2023 09:00:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/28/2023 08:45:44 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM